Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
38 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science